10-QFiling Date: Apr 30, 2026
Dexcom (DXCM) 10-Q (Apr 30, 2026)
dxcm-20260331
View SEC Filing
ACC: 0001093557-26-000073
Key Financial Metrics3M Mar'26 · 2026-03-31
Revenue$1.19B
Net Income$199.5M
Total Assets$6.63B
Stockholders' Equity$2.96B
Operating Cash Flow$525.6M